Status:
TERMINATED
Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia
Lead Sponsor:
John Uckele
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study investigates whether low dose aspirin combined with progesterone will decrease the risk of preeclampsia in pregnant women with a history of preeclampsia in a previous pregnancy.
Detailed Description
Recent advances have shown that certain proteins may be present in a pregnant woman's blood very early in pregnancy which can predict who is at the highest risk for developing preeclampsia. These prot...
Eligibility Criteria
Inclusion
- pregnant patients with a previous history of preeclampsia in the immediate preceding pregnancy.
- 18 to 45 years of age will be included.
Exclusion
- Patients with chronic hypertension
- children (age \< 17 years)
- Patients that are currently taking anti-psychotics or Selective Serotonin Re-uptake Inhibitors
- patients on medications which may be detrimental to the study interpretation will also be excluded at the principal investigator's discretion.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00719537
Start Date
July 1 2008
End Date
March 1 2011
Last Update
April 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073